PortfoliosLab logo

Bolt Biotherapeutics, Inc. (BOLT)

Equity · Currency in USD · Last updated Mar 24, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Bolt Biotherapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $407 for a total return of roughly -95.93%. All prices are adjusted for splits and dividends.

BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BOLT

Bolt Biotherapeutics, Inc.


Bolt Biotherapeutics, Inc. had a return of 0.77% year-to-date (YTD) and -57.61% in the last 12 months. Over the past 10 years, Bolt Biotherapeutics, Inc. had an annualized return of -77.85%, while the S&P 500 had an annualized return of 0.75%, indicating that Bolt Biotherapeutics, Inc. did not perform as well as the benchmark.

1 month-12.08%-3.20%
6 months-25.57%4.19%
1 year-57.61%-12.48%
5 years (annualized)-77.85%0.75%
10 years (annualized)-77.85%0.75%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bolt Biotherapeutics, Inc. Sharpe ratio is -0.80. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Bolt Biotherapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Bolt Biotherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bolt Biotherapeutics, Inc. is 96.84%, recorded on Dec 20, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-96.84%Mar 18, 2021445Dec 20, 2022
-22.7%Feb 11, 202111Feb 26, 20217Mar 9, 202118
-0.51%Mar 15, 20211Mar 15, 20211Mar 16, 20212
-0.2%Mar 10, 20211Mar 10, 20211Mar 11, 20212

Volatility Chart

Current Bolt Biotherapeutics, Inc. volatility is 88.29%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)